| 0 |
CHOLANGIOSARCOMA |
3 |
0.3750 |
| 1 |
DELAYED FOLLICULAR RIPENING |
1 |
0.3333 |
| 2 |
OVARIAN HYPERSTIMULATION SYNDROME |
434 |
0.1860 |
| 3 |
POOR RESPONSE TO OVULATION INDUCTION |
2 |
0.1818 |
| 4 |
MALIGNANT HYDATIDIFORM MOLE |
1 |
0.1667 |
| 5 |
PREMATURE OVULATION |
12 |
0.1538 |
| 6 |
HETEROTOPIC PREGNANCY |
9 |
0.1429 |
| 7 |
PROTEIN S ABNORMAL |
2 |
0.1429 |
| 8 |
HERMAPHRODITISM |
1 |
0.1111 |
| 9 |
OVARIAN NECROSIS |
7 |
0.1111 |
| 10 |
GONADAL DYSGENESIS |
1 |
0.1000 |
| 11 |
CYSTOSARCOMA PHYLLODES |
1 |
0.1000 |
| 12 |
OVARIAN TORSION |
8 |
0.0964 |
| 13 |
THROMBIN-ANTITHROMBIN III COMPLEX INCREASED |
2 |
0.0952 |
| 14 |
HOFFMANN'S SIGN |
1 |
0.0909 |
| 15 |
OPTIC NERVE SHEATH MENINGIOMA |
2 |
0.0909 |
| 16 |
MULTIPLE PREGNANCY |
16 |
0.0894 |
| 17 |
VAGINAL CUFF DEHISCENCE |
2 |
0.0667 |
| 18 |
OMENTUM NEOPLASM |
1 |
0.0667 |
| 19 |
FAILED IN VITRO FERTILISATION |
4 |
0.0656 |
| 20 |
PREGNANCY OF UNKNOWN LOCATION |
1 |
0.0588 |
| 21 |
CORNEAL LIGHT REFLEX TEST ABNORMAL |
1 |
0.0588 |
| 22 |
HAEMOCONCENTRATION |
10 |
0.0578 |
| 23 |
CLEAR CELL ENDOMETRIAL CARCINOMA |
1 |
0.0556 |
| 24 |
OOCYTE HARVEST |
1 |
0.0526 |
| 25 |
INTRACRANIAL ARTERY DISSECTION |
1 |
0.0526 |
| 26 |
DIMINISHED OVARIAN RESERVE |
1 |
0.0526 |
| 27 |
OVARIAN HAEMORRHAGE |
12 |
0.0506 |
| 28 |
HUMAN CHORIONIC GONADOTROPIN NEGATIVE |
1 |
0.0476 |
| 29 |
URETEROCELE |
2 |
0.0465 |
| 30 |
OESTRADIOL ABNORMAL |
3 |
0.0455 |
| 31 |
BLOOD GONADOTROPHIN INCREASED |
1 |
0.0400 |
| 32 |
MEDICAL OBSERVATION ABNORMAL |
1 |
0.0385 |
| 33 |
BLOOD HUMAN CHORIONIC GONADOTROPIN DECREASED |
1 |
0.0357 |
| 34 |
OVARIAN CYST TORSION |
2 |
0.0339 |
| 35 |
HEPATOBLASTOMA |
3 |
0.0309 |
| 36 |
CONJOINED TWINS |
3 |
0.0303 |
| 37 |
CONGENITAL HEPATOBILIARY ANOMALY |
1 |
0.0294 |
| 38 |
OBSTETRIC PROCEDURE COMPLICATION |
1 |
0.0270 |
| 39 |
PELVIC PERITONEAL ADHESIONS |
1 |
0.0263 |
| 40 |
BLOOD OESTROGEN INCREASED |
15 |
0.0255 |
| 41 |
OVARIAN ENLARGEMENT |
9 |
0.0234 |
| 42 |
PROGESTERONE ABNORMAL |
1 |
0.0222 |
| 43 |
POLYMICROGYRIA |
1 |
0.0222 |
| 44 |
PELVIC FLUID COLLECTION |
15 |
0.0213 |
| 45 |
BLOOD VISCOSITY ABNORMAL |
2 |
0.0211 |
| 46 |
ABORTION SPONTANEOUS INCOMPLETE |
2 |
0.0206 |
| 47 |
CONGENITAL GENITAL MALFORMATION FEMALE |
1 |
0.0204 |
| 48 |
PRADER-WILLI SYNDROME |
1 |
0.0196 |
| 49 |
TRISOMY 13 |
2 |
0.0196 |
| 50 |
MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE |
3 |
0.0195 |
| 51 |
ANOVULATORY CYCLE |
4 |
0.0193 |
| 52 |
ADNEXAL TORSION |
6 |
0.0189 |
| 53 |
BREAST INJURY |
3 |
0.0184 |
| 54 |
BASILAR ARTERY OCCLUSION |
3 |
0.0181 |
| 55 |
ABORTION THREATENED |
9 |
0.0181 |
| 56 |
HUMAN CHORIONIC GONADOTROPIN POSITIVE |
1 |
0.0175 |
| 57 |
HUMAN CHORIONIC GONADOTROPIN ABNORMAL |
1 |
0.0172 |
| 58 |
CIRCULATORY FAILURE NEONATAL |
1 |
0.0169 |
| 59 |
NATURAL KILLER CELL COUNT INCREASED |
1 |
0.0167 |
| 60 |
IN VITRO FERTILISATION |
3 |
0.0166 |
| 61 |
TUBO-OVARIAN ABSCESS |
4 |
0.0164 |
| 62 |
UMBILICAL CORD PROLAPSE |
2 |
0.0163 |
| 63 |
BLOOD LUTEINISING HORMONE INCREASED |
4 |
0.0163 |
| 64 |
DUODENAL ATRESIA |
2 |
0.0163 |
| 65 |
NIPPLE ENLARGEMENT |
1 |
0.0161 |
| 66 |
ECTOPIC PREGNANCY TERMINATION |
1 |
0.0159 |
| 67 |
BLOOD FOLLICLE STIMULATING HORMONE ABNORMAL |
1 |
0.0154 |
| 68 |
GARDNERELLA INFECTION |
1 |
0.0145 |
| 69 |
ENDOTOXIC SHOCK |
1 |
0.0145 |
| 70 |
CARDIAC PSEUDOANEURYSM |
1 |
0.0145 |
| 71 |
OCULOAURICULOVERTEBRAL DYSPLASIA |
1 |
0.0139 |
| 72 |
TWIN PREGNANCY |
11 |
0.0131 |
| 73 |
OVARIAN DISORDER |
12 |
0.0128 |
| 74 |
HAEMORRHAGIC OVARIAN CYST |
7 |
0.0122 |
| 75 |
ENCEPHALOCELE |
3 |
0.0120 |
| 76 |
ABDOMINAL WALL ANOMALY |
1 |
0.0112 |
| 77 |
EXCESSIVE EXERCISE |
1 |
0.0105 |
| 78 |
HAEMORRHAGIC ASCITES |
3 |
0.0105 |
| 79 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
3 |
0.0101 |
| 80 |
PERFORMANCE ENHANCING PRODUCT USE |
1 |
0.0101 |
| 81 |
CEPHALO-PELVIC DISPROPORTION |
2 |
0.0100 |
| 82 |
OESTRADIOL INCREASED |
3 |
0.0100 |
| 83 |
DRUG EXPOSURE BEFORE PREGNANCY |
10 |
0.0099 |
| 84 |
FOETAL MOVEMENTS DECREASED |
1 |
0.0098 |
| 85 |
PRODUCT ADMINISTRATION ISSUE |
2 |
0.0096 |
| 86 |
OVARIAN FAILURE |
5 |
0.0093 |
| 87 |
BIOCHEMICAL PREGNANCY |
1 |
0.0093 |
| 88 |
PLACENTA ACCRETA |
2 |
0.0092 |
| 89 |
ECTOPIC PREGNANCY |
28 |
0.0091 |
| 90 |
PELVIC HAEMATOMA |
4 |
0.0091 |
| 91 |
BENIGN HYDATIDIFORM MOLE |
3 |
0.0091 |
| 92 |
CRANIOPHARYNGIOMA |
3 |
0.0090 |
| 93 |
OVARIAN RUPTURE |
1 |
0.0085 |
| 94 |
OVULATION DISORDER |
1 |
0.0085 |
| 95 |
PELVIC ADHESIONS |
2 |
0.0084 |
| 96 |
LACRIMATION DISORDER |
1 |
0.0082 |
| 97 |
INTESTINAL MALROTATION |
2 |
0.0076 |
| 98 |
ANTITHROMBIN III DECREASED |
2 |
0.0073 |
| 99 |
EFFUSION |
10 |
0.0073 |
| 100 |
CHROMOSOME ABNORMALITY |
1 |
0.0072 |
| 101 |
BONE FISSURE |
3 |
0.0072 |
| 102 |
FORCED EXPIRATORY VOLUME ABNORMAL |
1 |
0.0069 |
| 103 |
NEONATAL RESPIRATORY ARREST |
1 |
0.0068 |
| 104 |
FALLOPIAN TUBE DISORDER |
2 |
0.0068 |
| 105 |
CONGENITAL SCOLIOSIS |
1 |
0.0066 |
| 106 |
PERITONEAL HAEMORRHAGE |
9 |
0.0065 |
| 107 |
RENAL ARTERY THROMBOSIS |
2 |
0.0065 |
| 108 |
OVARIAN ABSCESS |
1 |
0.0064 |
| 109 |
PREGNANCY INDUCED HYPERTENSION |
1 |
0.0062 |
| 110 |
OESTRADIOL DECREASED |
2 |
0.0062 |
| 111 |
MALIGNANT MELANOMA STAGE II |
1 |
0.0061 |
| 112 |
MENSTRUATION NORMAL |
2 |
0.0060 |
| 113 |
OVARIAN ADENOMA |
1 |
0.0060 |
| 114 |
FOETAL CHROMOSOME ABNORMALITY |
1 |
0.0059 |
| 115 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
40 |
0.0058 |
| 116 |
GENITALIA EXTERNAL AMBIGUOUS |
1 |
0.0058 |
| 117 |
ANAEMIA OF PREGNANCY |
1 |
0.0058 |
| 118 |
HAEMATOCRIT INCREASED |
13 |
0.0057 |
| 119 |
PUNCTURE SITE HAEMORRHAGE |
4 |
0.0056 |
| 120 |
BLOOD LUTEINISING HORMONE DECREASED |
1 |
0.0056 |
| 121 |
BASILAR ARTERY THROMBOSIS |
1 |
0.0056 |
| 122 |
HYDROMETRA |
1 |
0.0054 |
| 123 |
ADMINISTRATION SITE DISCOMFORT |
1 |
0.0053 |
| 124 |
INJECTION SITE ECZEMA |
1 |
0.0052 |
| 125 |
RENAL DYSPLASIA |
2 |
0.0052 |
| 126 |
RUPTURED ECTOPIC PREGNANCY |
4 |
0.0052 |
| 127 |
BLIGHTED OVUM |
2 |
0.0051 |
| 128 |
PROLACTIN-PRODUCING PITUITARY TUMOUR |
1 |
0.0051 |
| 129 |
NECROTISING ENTEROCOLITIS NEONATAL |
2 |
0.0049 |
| 130 |
ANTEPARTUM HAEMORRHAGE |
2 |
0.0048 |
| 131 |
OPTIC DISC DISORDER |
1 |
0.0048 |
| 132 |
BACTERIA URINE IDENTIFIED |
1 |
0.0047 |
| 133 |
FEMALE REPRODUCTIVE TRACT DISORDER |
1 |
0.0046 |
| 134 |
PELVIC HAEMORRHAGE |
1 |
0.0046 |
| 135 |
CYST RUPTURE |
3 |
0.0044 |
| 136 |
ABORTION |
12 |
0.0041 |
| 137 |
TENSION |
25 |
0.0041 |
| 138 |
NEONATAL RESPIRATORY FAILURE |
2 |
0.0040 |
| 139 |
CONGENITAL HYDROCEPHALUS |
2 |
0.0039 |
| 140 |
ABORTION MISSED |
5 |
0.0039 |
| 141 |
OVARIAN NEOPLASM |
3 |
0.0039 |
| 142 |
JUGULAR VEIN THROMBOSIS |
7 |
0.0039 |
| 143 |
CEREBRAL CALCIFICATION |
1 |
0.0037 |
| 144 |
INTRA-UTERINE DEATH |
6 |
0.0037 |
| 145 |
AMAUROSIS |
3 |
0.0036 |
| 146 |
CARDIO-RESPIRATORY DISTRESS |
1 |
0.0035 |
| 147 |
ACUTE ABDOMEN |
5 |
0.0034 |
| 148 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
3 |
0.0033 |
| 149 |
ASCITES |
95 |
0.0032 |
| 150 |
PROGESTERONE DECREASED |
1 |
0.0032 |
| 151 |
OESOPHAGEAL ATRESIA |
2 |
0.0032 |
| 152 |
ALOPECIA TOTALIS |
1 |
0.0030 |
| 153 |
COAGULATION TIME SHORTENED |
1 |
0.0030 |
| 154 |
DRUG EFFECT FASTER THAN EXPECTED |
1 |
0.0030 |
| 155 |
WAIST CIRCUMFERENCE INCREASED |
3 |
0.0029 |
| 156 |
FEEDING DISORDER NEONATAL |
3 |
0.0029 |
| 157 |
BLOOD OESTROGEN DECREASED |
2 |
0.0028 |
| 158 |
GRANULOMATOUS LIVER DISEASE |
2 |
0.0028 |
| 159 |
TUMOUR NECROSIS |
3 |
0.0028 |
| 160 |
CERVIX DISORDER |
2 |
0.0028 |
| 161 |
AMNIOTIC CAVITY INFECTION |
2 |
0.0028 |
| 162 |
RENAL INFARCT |
4 |
0.0028 |
| 163 |
ABSCESS BACTERIAL |
1 |
0.0028 |
| 164 |
PRODUCT COMPOUNDING QUALITY ISSUE |
1 |
0.0027 |
| 165 |
CYTOGENETIC ABNORMALITY |
3 |
0.0027 |
| 166 |
HYPEREMESIS GRAVIDARUM |
1 |
0.0026 |
| 167 |
POLYCYSTIC OVARIAN SYNDROME |
1 |
0.0026 |
| 168 |
MACROCEPHALY |
1 |
0.0026 |
| 169 |
BREAST FEEDING |
2 |
0.0026 |
| 170 |
BLOOD FOLLICLE STIMULATING HORMONE INCREASED |
1 |
0.0026 |
| 171 |
PREGNANCY TEST POSITIVE |
1 |
0.0025 |
| 172 |
INTRA-ABDOMINAL HAEMORRHAGE |
6 |
0.0025 |
| 173 |
PREMATURE RUPTURE OF MEMBRANES |
6 |
0.0025 |
| 174 |
BRONCHOPULMONARY DYSPLASIA |
2 |
0.0025 |
| 175 |
ENDOMETRIAL DISORDER |
1 |
0.0024 |
| 176 |
ARTERY DISSECTION |
1 |
0.0024 |
| 177 |
INVASIVE BREAST CARCINOMA |
1 |
0.0024 |
| 178 |
HYPOCAPNIA |
1 |
0.0024 |
| 179 |
GENE MUTATION IDENTIFICATION TEST POSITIVE |
1 |
0.0024 |
| 180 |
GASTRODUODENAL ULCER |
1 |
0.0024 |
| 181 |
PYLORIC STENOSIS |
2 |
0.0024 |
| 182 |
ADNEXA UTERI PAIN |
3 |
0.0023 |
| 183 |
CHOROIDAL NEOVASCULARISATION |
2 |
0.0023 |
| 184 |
CONGENITAL MUSCULOSKELETAL ANOMALY |
1 |
0.0023 |
| 185 |
OLIGURIA |
14 |
0.0023 |
| 186 |
BIOPSY BONE MARROW ABNORMAL |
1 |
0.0022 |
| 187 |
SUSPECTED PRODUCT QUALITY ISSUE |
4 |
0.0022 |
| 188 |
PREMENSTRUAL SYNDROME |
3 |
0.0022 |
| 189 |
PREGNANCY TEST FALSE POSITIVE |
1 |
0.0021 |
| 190 |
DYSPHASIA |
1 |
0.0021 |
| 191 |
NEUROLOGICAL EXAMINATION ABNORMAL |
1 |
0.0021 |
| 192 |
THERAPEUTIC RESPONSE INCREASED |
2 |
0.0021 |
| 193 |
HYPERCOAGULATION |
4 |
0.0021 |
| 194 |
MORPHOEA |
1 |
0.0021 |
| 195 |
INTRAVENTRICULAR HAEMORRHAGE NEONATAL |
1 |
0.0021 |
| 196 |
CERVICAL INCOMPETENCE |
1 |
0.0020 |
| 197 |
CEREBRAL ARTERY THROMBOSIS |
1 |
0.0019 |
| 198 |
UTERINE CONTRACTIONS DURING PREGNANCY |
2 |
0.0019 |
| 199 |
POSTURING |
1 |
0.0019 |
| 200 |
HYPOPERFUSION |
2 |
0.0019 |
| 201 |
ABDOMINAL DISTENSION |
198 |
0.0019 |
| 202 |
NEUROGENIC SHOCK |
1 |
0.0018 |
| 203 |
MORNING SICKNESS |
1 |
0.0018 |
| 204 |
SUBCLAVIAN VEIN THROMBOSIS |
2 |
0.0018 |
| 205 |
ADMINISTRATION SITE PAIN |
2 |
0.0017 |
| 206 |
ABORTION SPONTANEOUS |
69 |
0.0017 |
| 207 |
LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR |
1 |
0.0017 |
| 208 |
CEREBRAL VENOUS THROMBOSIS |
3 |
0.0017 |
| 209 |
NIPPLE DISORDER |
1 |
0.0016 |
| 210 |
ADENOCARCINOMA OF COLON |
3 |
0.0016 |
| 211 |
BREECH PRESENTATION |
2 |
0.0016 |
| 212 |
TRISOMY 21 |
2 |
0.0016 |
| 213 |
LARYNGEAL DISCOMFORT |
1 |
0.0016 |
| 214 |
APGAR SCORE LOW |
2 |
0.0016 |
| 215 |
BREAST ENLARGEMENT |
5 |
0.0015 |
| 216 |
OVARIAN CYST |
15 |
0.0015 |
| 217 |
COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS |
1 |
0.0015 |
| 218 |
CAESAREAN SECTION |
17 |
0.0015 |
| 219 |
DEATH NEONATAL |
2 |
0.0014 |
| 220 |
CHRONIC FATIGUE SYNDROME |
2 |
0.0014 |
| 221 |
MATERNAL DRUGS AFFECTING FOETUS |
11 |
0.0014 |
| 222 |
PRODUCT DESIGN ISSUE |
1 |
0.0014 |
| 223 |
DRUG LEVEL DECREASED |
14 |
0.0014 |
| 224 |
HEMIANOPIA HOMONYMOUS |
1 |
0.0014 |
| 225 |
FOETAL DEATH |
7 |
0.0013 |
| 226 |
BRAIN HERNIATION |
4 |
0.0013 |
| 227 |
INFERTILITY |
2 |
0.0013 |
| 228 |
DRUG EXPOSURE DURING PREGNANCY |
45 |
0.0013 |
| 229 |
PREGNANCY |
26 |
0.0013 |
| 230 |
MYELITIS |
2 |
0.0013 |
| 231 |
POLYCYSTIC OVARIES |
2 |
0.0013 |
| 232 |
UTERINE DISORDER |
3 |
0.0013 |
| 233 |
HYPOTONIA NEONATAL |
2 |
0.0013 |
| 234 |
FOETAL GROWTH RETARDATION |
1 |
0.0013 |
| 235 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 236 |
LIMB MALFORMATION |
1 |
0.0013 |
| 237 |
OVARIAN CANCER RECURRENT |
2 |
0.0012 |
| 238 |
ENDOMETRIAL HYPERPLASIA |
1 |
0.0012 |
| 239 |
COVID-19 IMMUNISATION |
1 |
0.0012 |
| 240 |
LIP PRURITUS |
1 |
0.0012 |
| 241 |
PATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0012 |
| 242 |
EOSINOPHILIC PNEUMONIA ACUTE |
1 |
0.0012 |
| 243 |
ABSCESS DRAINAGE |
1 |
0.0012 |
| 244 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
81 |
0.0011 |
| 245 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
1 |
0.0011 |
| 246 |
UTERINE POLYP |
2 |
0.0011 |
| 247 |
IMPLANT SITE PRURITUS |
1 |
0.0011 |
| 248 |
MUSCLE NECROSIS |
1 |
0.0011 |
| 249 |
RED BLOOD CELL COUNT INCREASED |
3 |
0.0011 |
| 250 |
EXTENSOR PLANTAR RESPONSE |
1 |
0.0011 |
| 251 |
FOETAL HEART RATE ABNORMAL |
1 |
0.0011 |
| 252 |
PUPILLARY REFLEX IMPAIRED |
2 |
0.0011 |
| 253 |
MENINGIOMA BENIGN |
1 |
0.0011 |
| 254 |
ADVERSE FOOD REACTION |
1 |
0.0011 |
| 255 |
ABORTION INCOMPLETE |
2 |
0.0011 |
| 256 |
PROTEIN TOTAL DECREASED |
4 |
0.0011 |
| 257 |
ABORTION INDUCED |
10 |
0.0011 |
| 258 |
PELVIC DISCOMFORT |
1 |
0.0011 |
| 259 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 260 |
URINE OUTPUT DECREASED |
9 |
0.0010 |
| 261 |
CONTINUOUS HAEMODIAFILTRATION |
1 |
0.0010 |
| 262 |
DUST ALLERGY |
1 |
0.0010 |
| 263 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 264 |
HEMIANOPIA |
1 |
0.0010 |
| 265 |
ANTISOCIAL BEHAVIOUR |
1 |
0.0010 |
| 266 |
ACQUIRED HAEMOPHILIA |
1 |
0.0010 |
| 267 |
THYROIDITIS |
3 |
0.0010 |
| 268 |
BENIGN BREAST NEOPLASM |
1 |
0.0010 |
| 269 |
GASTRIC PH DECREASED |
1 |
0.0010 |
| 270 |
DEMYELINATION |
4 |
0.0010 |
| 271 |
CAPILLARY LEAK SYNDROME |
2 |
0.0010 |
| 272 |
INJECTION SITE HYPERSENSITIVITY |
3 |
0.0010 |
| 273 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
0.0009 |
| 274 |
LANGUAGE DISORDER |
2 |
0.0009 |
| 275 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 276 |
CEREBELLAR SYNDROME |
2 |
0.0009 |
| 277 |
GENERALISED TONIC-CLONIC SEIZURE |
15 |
0.0009 |
| 278 |
POOR QUALITY DEVICE USED |
9 |
0.0009 |
| 279 |
CLEFT LIP AND PALATE |
1 |
0.0009 |
| 280 |
CRYPTORCHISM |
1 |
0.0009 |
| 281 |
PREMATURE LABOUR |
5 |
0.0009 |
| 282 |
OESTROGEN RECEPTOR ASSAY POSITIVE |
1 |
0.0009 |
| 283 |
LIGAMENT INJURY |
1 |
0.0009 |
| 284 |
ERYTHEMA NODOSUM |
3 |
0.0009 |
| 285 |
FIBRIN D DIMER INCREASED |
3 |
0.0008 |
| 286 |
GESTATIONAL DIABETES |
4 |
0.0008 |
| 287 |
RECALLED PRODUCT ADMINISTERED |
8 |
0.0008 |
| 288 |
ASTHMATIC CRISIS |
3 |
0.0008 |
| 289 |
CEREBRAL ARTERY EMBOLISM |
1 |
0.0008 |
| 290 |
UTERINE LEIOMYOMA |
6 |
0.0008 |
| 291 |
EYE OEDEMA |
2 |
0.0008 |
| 292 |
PALATAL OEDEMA |
1 |
0.0008 |
| 293 |
BLOOD UREA DECREASED |
1 |
0.0008 |
| 294 |
OVARIAN CYST RUPTURED |
1 |
0.0008 |
| 295 |
IATROGENIC INJURY |
1 |
0.0008 |
| 296 |
PANIC DISORDER |
3 |
0.0008 |
| 297 |
BREAST SWELLING |
2 |
0.0007 |
| 298 |
ECHOCARDIOGRAM ABNORMAL |
1 |
0.0007 |
| 299 |
PRERENAL FAILURE |
1 |
0.0007 |
| 300 |
INJECTION SITE IRRITATION |
9 |
0.0007 |
| 301 |
PRECANCEROUS CELLS PRESENT |
1 |
0.0007 |
| 302 |
UTERINE HAEMORRHAGE |
3 |
0.0007 |
| 303 |
GENITAL RASH |
1 |
0.0007 |
| 304 |
INJECTION SITE HYPOAESTHESIA |
1 |
0.0007 |
| 305 |
PELVIC VENOUS THROMBOSIS |
1 |
0.0007 |
| 306 |
MULTIPLE CONGENITAL ABNORMALITIES |
1 |
0.0007 |
| 307 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 308 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 309 |
ABDOMINAL PAIN LOWER |
17 |
0.0007 |
| 310 |
BLOOD CULTURE POSITIVE |
2 |
0.0007 |
| 311 |
ADHESION |
1 |
0.0007 |
| 312 |
HAEMOGLOBIN INCREASED |
3 |
0.0007 |
| 313 |
NEEDLE ISSUE |
19 |
0.0007 |
| 314 |
INTRACARDIAC THROMBUS |
2 |
0.0007 |
| 315 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 316 |
INFERTILITY FEMALE |
1 |
0.0006 |
| 317 |
PRODUCT DEPOSIT |
1 |
0.0006 |
| 318 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 319 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 320 |
ORTHOPNOEA |
2 |
0.0006 |
| 321 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
1 |
0.0006 |
| 322 |
ANTIPHOSPHOLIPID SYNDROME |
1 |
0.0006 |
| 323 |
HEPATITIS ACUTE |
4 |
0.0006 |
| 324 |
CARDIOVASCULAR INSUFFICIENCY |
1 |
0.0006 |
| 325 |
PRODUCT PREPARATION ISSUE |
4 |
0.0006 |
| 326 |
MATERNAL EXPOSURE DURING PREGNANCY |
54 |
0.0006 |
| 327 |
PELVIC PAIN |
11 |
0.0006 |
| 328 |
ANTIBODY TEST POSITIVE |
1 |
0.0006 |
| 329 |
GAZE PALSY |
1 |
0.0006 |
| 330 |
INJECTION SITE RASH |
18 |
0.0006 |
| 331 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 332 |
APLASIA PURE RED CELL |
2 |
0.0006 |
| 333 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0006 |
| 334 |
LACK OF INJECTION SITE ROTATION |
1 |
0.0006 |
| 335 |
INJECTION SITE DISCOMFORT |
6 |
0.0006 |
| 336 |
ALOPECIA AREATA |
1 |
0.0006 |
| 337 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
2 |
0.0006 |
| 338 |
INTRA-ABDOMINAL FLUID COLLECTION |
1 |
0.0006 |
| 339 |
FAECALOMA |
3 |
0.0005 |
| 340 |
THROMBOCYTOSIS |
2 |
0.0005 |
| 341 |
INTERMENSTRUAL BLEEDING |
3 |
0.0005 |
| 342 |
RETINOPATHY |
2 |
0.0005 |
| 343 |
HYDRONEPHROSIS |
4 |
0.0005 |
| 344 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 345 |
BREAST TENDERNESS |
4 |
0.0005 |
| 346 |
NARCOLEPSY |
1 |
0.0005 |
| 347 |
PLEURAL EFFUSION |
32 |
0.0005 |
| 348 |
OESOPHAGEAL ULCER |
2 |
0.0005 |
| 349 |
MOTION SICKNESS |
1 |
0.0005 |
| 350 |
CONVERSION DISORDER |
1 |
0.0005 |
| 351 |
HYPOALBUMINAEMIA |
4 |
0.0005 |
| 352 |
HYPERTRIGLYCERIDAEMIA |
3 |
0.0005 |
| 353 |
PATENT DUCTUS ARTERIOSUS |
2 |
0.0005 |
| 354 |
MUCOSAL DRYNESS |
1 |
0.0005 |
| 355 |
ABDOMINAL PAIN |
115 |
0.0005 |
| 356 |
INJECTION SITE PAIN |
151 |
0.0005 |
| 357 |
NIPPLE PAIN |
1 |
0.0005 |
| 358 |
CEREBRAL INFARCTION |
12 |
0.0005 |
| 359 |
SUBARACHNOID HAEMORRHAGE |
5 |
0.0005 |
| 360 |
POLYCYTHAEMIA |
1 |
0.0005 |
| 361 |
HYPOSPADIAS |
1 |
0.0005 |
| 362 |
INJECTION SITE PRURITUS |
32 |
0.0005 |
| 363 |
DILATATION VENTRICULAR |
1 |
0.0005 |
| 364 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 365 |
EAR SWELLING |
1 |
0.0005 |
| 366 |
PREMATURE BABY |
14 |
0.0005 |
| 367 |
AMYOTROPHIC LATERAL SCLEROSIS |
1 |
0.0005 |
| 368 |
JAW FRACTURE |
1 |
0.0005 |
| 369 |
FACIAL PALSY |
1 |
0.0005 |
| 370 |
BIPOLAR I DISORDER |
1 |
0.0005 |
| 371 |
ENDOMETRIAL CANCER |
1 |
0.0005 |
| 372 |
VULVOVAGINAL DISCOMFORT |
2 |
0.0005 |
| 373 |
INJECTION SITE BRUISING |
36 |
0.0005 |
| 374 |
ORAL PRURITUS |
1 |
0.0004 |
| 375 |
OVARIAN CANCER |
4 |
0.0004 |
| 376 |
CHEST DISCOMFORT |
44 |
0.0004 |
| 377 |
MASS |
6 |
0.0004 |
| 378 |
DYSMORPHISM |
1 |
0.0004 |
| 379 |
METASTASIS |
3 |
0.0004 |
| 380 |
MYOPIA |
1 |
0.0004 |
| 381 |
HYPOVOLAEMIC SHOCK |
2 |
0.0004 |
| 382 |
STILLBIRTH |
2 |
0.0004 |
| 383 |
ENTEROCOCCAL INFECTION |
2 |
0.0004 |
| 384 |
HORMONE LEVEL ABNORMAL |
2 |
0.0004 |
| 385 |
PHARYNGEAL SWELLING |
4 |
0.0004 |
| 386 |
ABDOMINAL TENDERNESS |
2 |
0.0004 |
| 387 |
INJECTION SITE ABSCESS |
1 |
0.0004 |
| 388 |
PERSECUTORY DELUSION |
1 |
0.0004 |
| 389 |
LACTOSE INTOLERANCE |
1 |
0.0004 |
| 390 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 391 |
PLATELET COUNT INCREASED |
5 |
0.0004 |
| 392 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 393 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
1 |
0.0004 |
| 394 |
AFFECTIVE DISORDER |
3 |
0.0004 |
| 395 |
GASTRITIS |
10 |
0.0004 |
| 396 |
POOR QUALITY PRODUCT ADMINISTERED |
4 |
0.0004 |
| 397 |
INJECTION SITE MASS |
14 |
0.0004 |
| 398 |
INJECTION SITE REACTION |
26 |
0.0004 |
| 399 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 400 |
VAGINAL HAEMORRHAGE |
16 |
0.0004 |
| 401 |
HYDROCEPHALUS |
2 |
0.0004 |
| 402 |
ABNORMAL FAECES |
3 |
0.0004 |
| 403 |
CLONUS |
1 |
0.0004 |
| 404 |
ESCHERICHIA INFECTION |
3 |
0.0004 |
| 405 |
DEAFNESS UNILATERAL |
2 |
0.0004 |
| 406 |
MENSTRUAL DISORDER |
3 |
0.0004 |
| 407 |
EMBOLISM |
3 |
0.0004 |
| 408 |
EOSINOPHILIC OESOPHAGITIS |
1 |
0.0004 |
| 409 |
INTRACRANIAL PRESSURE INCREASED |
2 |
0.0004 |
| 410 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 411 |
DISSEMINATED INTRAVASCULAR COAGULATION |
5 |
0.0004 |
| 412 |
CHOLECYSTITIS ACUTE |
2 |
0.0004 |
| 413 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 414 |
HOT FLUSH |
26 |
0.0003 |
| 415 |
HAEMOTHORAX |
1 |
0.0003 |
| 416 |
TYPE 1 DIABETES MELLITUS |
2 |
0.0003 |
| 417 |
CEREBROVASCULAR DISORDER |
1 |
0.0003 |
| 418 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 419 |
CRANIOCEREBRAL INJURY |
1 |
0.0003 |
| 420 |
KERATITIS |
1 |
0.0003 |
| 421 |
MASTICATION DISORDER |
1 |
0.0003 |
| 422 |
DYSAESTHESIA |
1 |
0.0003 |
| 423 |
INJECTION SITE URTICARIA |
8 |
0.0003 |
| 424 |
BRAIN DEATH |
1 |
0.0003 |
| 425 |
CYST |
4 |
0.0003 |
| 426 |
INJECTION SITE DISCOLOURATION |
4 |
0.0003 |
| 427 |
ASPARTATE AMINOTRANSFERASE INCREASED |
17 |
0.0003 |
| 428 |
INJECTION SITE ERYTHEMA |
39 |
0.0003 |
| 429 |
BILE DUCT STONE |
1 |
0.0003 |
| 430 |
WHITE BLOOD CELL COUNT INCREASED |
12 |
0.0003 |
| 431 |
MYDRIASIS |
4 |
0.0003 |
| 432 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 433 |
PROCTALGIA |
2 |
0.0003 |
| 434 |
GENITAL HAEMORRHAGE |
4 |
0.0003 |
| 435 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 436 |
OTITIS MEDIA |
1 |
0.0003 |
| 437 |
VAGINAL DISCHARGE |
3 |
0.0003 |
| 438 |
HEPATIC CYST |
1 |
0.0003 |
| 439 |
CARBOHYDRATE ANTIGEN 125 INCREASED |
1 |
0.0003 |
| 440 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
5 |
0.0003 |
| 441 |
EXPOSURE DURING PREGNANCY |
18 |
0.0003 |
| 442 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 443 |
VENTRICULAR EXTRASYSTOLES |
3 |
0.0003 |
| 444 |
POLYMENORRHOEA |
1 |
0.0003 |
| 445 |
TENDERNESS |
3 |
0.0003 |
| 446 |
HYPERREFLEXIA |
1 |
0.0003 |
| 447 |
MUSCLE CONTRACTIONS INVOLUNTARY |
1 |
0.0003 |
| 448 |
MOOD SWINGS |
9 |
0.0003 |
| 449 |
HEPATOCELLULAR INJURY |
4 |
0.0003 |
| 450 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 451 |
BREAST PAIN |
3 |
0.0003 |
| 452 |
HYPERTHYROIDISM |
4 |
0.0003 |
| 453 |
CAROTID ARTERY OCCLUSION |
1 |
0.0003 |
| 454 |
HYPOMANIA |
1 |
0.0003 |
| 455 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 456 |
BURNING SENSATION |
19 |
0.0003 |
| 457 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 458 |
NEURODERMATITIS |
1 |
0.0003 |
| 459 |
PULMONARY MASS |
4 |
0.0003 |
| 460 |
BLOOD SODIUM DECREASED |
5 |
0.0003 |
| 461 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 462 |
ALANINE AMINOTRANSFERASE INCREASED |
16 |
0.0003 |
| 463 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 464 |
MULTIPLE ALLERGIES |
2 |
0.0003 |
| 465 |
OESOPHAGEAL PAIN |
1 |
0.0003 |
| 466 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 467 |
LOW BIRTH WEIGHT BABY |
2 |
0.0003 |
| 468 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 469 |
HYPERPHAGIA |
1 |
0.0003 |
| 470 |
MUSCLE HAEMORRHAGE |
1 |
0.0002 |
| 471 |
HYPONATRAEMIA |
14 |
0.0002 |
| 472 |
BURSITIS |
3 |
0.0002 |
| 473 |
HOMICIDAL IDEATION |
1 |
0.0002 |
| 474 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 475 |
PERIPHERAL VENOUS DISEASE |
1 |
0.0002 |
| 476 |
GOITRE |
1 |
0.0002 |
| 477 |
ARTHRITIS BACTERIAL |
1 |
0.0002 |
| 478 |
HYPERAESTHESIA |
2 |
0.0002 |
| 479 |
MANIA |
4 |
0.0002 |
| 480 |
VENTRICULAR TACHYCARDIA |
4 |
0.0002 |
| 481 |
PERITONITIS |
5 |
0.0002 |
| 482 |
BREAST CANCER STAGE II |
2 |
0.0002 |
| 483 |
LIVE BIRTH |
2 |
0.0002 |
| 484 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 485 |
CIRCULATORY COLLAPSE |
4 |
0.0002 |
| 486 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 487 |
ABSCESS LIMB |
1 |
0.0002 |
| 488 |
RETCHING |
5 |
0.0002 |
| 489 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 490 |
SKIN HYPERPIGMENTATION |
2 |
0.0002 |
| 491 |
CHAPPED LIPS |
1 |
0.0002 |
| 492 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
6 |
0.0002 |
| 493 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 494 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 495 |
HEADACHE |
141 |
0.0002 |
| 496 |
TRANSAMINASES INCREASED |
5 |
0.0002 |
| 497 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 498 |
PAPILLOEDEMA |
1 |
0.0002 |
| 499 |
LEUKOCYTOSIS |
4 |
0.0002 |
| 500 |
TACHYPNOEA |
3 |
0.0002 |
| 501 |
PALLOR |
6 |
0.0002 |
| 502 |
OPTIC NEURITIS |
2 |
0.0002 |
| 503 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 504 |
HIDRADENITIS |
2 |
0.0002 |
| 505 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 506 |
DISEASE COMPLICATION |
1 |
0.0002 |
| 507 |
CENTRAL NERVOUS SYSTEM LESION |
3 |
0.0002 |
| 508 |
ISCHAEMIA |
1 |
0.0002 |
| 509 |
CHRONIC MYELOID LEUKAEMIA |
1 |
0.0002 |
| 510 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 511 |
LACERATION |
2 |
0.0002 |
| 512 |
LEUKAEMIA |
2 |
0.0002 |
| 513 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 514 |
LIP SWELLING |
7 |
0.0002 |
| 515 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 516 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 517 |
AFFECT LABILITY |
2 |
0.0002 |
| 518 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
7 |
0.0002 |
| 519 |
ANOSMIA |
3 |
0.0002 |
| 520 |
THERAPY NON-RESPONDER |
9 |
0.0002 |
| 521 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 522 |
OSTEOPENIA |
3 |
0.0002 |
| 523 |
PHARYNGEAL OEDEMA |
3 |
0.0002 |
| 524 |
ENDOCARDITIS |
1 |
0.0002 |
| 525 |
PRODUCT PREPARATION ERROR |
4 |
0.0002 |
| 526 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 527 |
MENINGIOMA |
3 |
0.0002 |
| 528 |
PETECHIAE |
2 |
0.0002 |
| 529 |
PRODUCT QUALITY ISSUE |
26 |
0.0002 |
| 530 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 531 |
CATATONIA |
1 |
0.0002 |
| 532 |
ULCER |
3 |
0.0002 |
| 533 |
PREMATURE DELIVERY |
3 |
0.0002 |
| 534 |
NYSTAGMUS |
1 |
0.0002 |
| 535 |
HYPOTHYROIDISM |
6 |
0.0002 |
| 536 |
HEPATIC FUNCTION ABNORMAL |
7 |
0.0002 |
| 537 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 538 |
FOOD POISONING |
1 |
0.0002 |
| 539 |
BLOOD BILIRUBIN INCREASED |
5 |
0.0002 |
| 540 |
NORMAL NEWBORN |
1 |
0.0002 |
| 541 |
SKIN LACERATION |
2 |
0.0002 |
| 542 |
ASTHENOPIA |
1 |
0.0002 |
| 543 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 544 |
NECROSIS |
1 |
0.0002 |
| 545 |
HYPERTONIA |
1 |
0.0002 |
| 546 |
SHOCK |
4 |
0.0002 |
| 547 |
HYPERVENTILATION |
1 |
0.0002 |
| 548 |
POST PROCEDURAL HAEMORRHAGE |
2 |
0.0002 |
| 549 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 550 |
SYNCOPE |
17 |
0.0002 |
| 551 |
NAUSEA |
133 |
0.0002 |
| 552 |
IRRITABILITY |
10 |
0.0002 |
| 553 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 554 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 555 |
INGUINAL HERNIA |
1 |
0.0002 |
| 556 |
NO THERAPEUTIC RESPONSE |
2 |
0.0002 |
| 557 |
ACCIDENTAL OVERDOSE |
6 |
0.0002 |
| 558 |
MENISCUS INJURY |
1 |
0.0002 |
| 559 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 560 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 561 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 562 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 563 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 564 |
BRAIN OEDEMA |
2 |
0.0002 |
| 565 |
TACHYCARDIA |
14 |
0.0002 |
| 566 |
POST PROCEDURAL COMPLICATION |
3 |
0.0002 |
| 567 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 568 |
DIPLOPIA |
4 |
0.0002 |
| 569 |
DEEP VEIN THROMBOSIS |
10 |
0.0002 |
| 570 |
PALPITATIONS |
18 |
0.0002 |
| 571 |
MENORRHAGIA |
3 |
0.0002 |
| 572 |
POLYP |
1 |
0.0002 |
| 573 |
ANKYLOSING SPONDYLITIS |
2 |
0.0002 |
| 574 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 575 |
DYSMENORRHOEA |
2 |
0.0002 |
| 576 |
MENINGITIS |
1 |
0.0001 |
| 577 |
SPINAL FRACTURE |
3 |
0.0001 |
| 578 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 579 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 580 |
THERAPEUTIC RESPONSE DECREASED |
9 |
0.0001 |
| 581 |
DYSPNOEA |
84 |
0.0001 |
| 582 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 583 |
DISCOMFORT |
9 |
0.0001 |
| 584 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 585 |
MOOD ALTERED |
4 |
0.0001 |
| 586 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 587 |
PRODUCT USE IN UNAPPROVED INDICATION |
36 |
0.0001 |
| 588 |
JOINT EFFUSION |
1 |
0.0001 |
| 589 |
ENCEPHALITIS |
1 |
0.0001 |
| 590 |
APHONIA |
2 |
0.0001 |
| 591 |
EXTRASYSTOLES |
1 |
0.0001 |
| 592 |
HALLUCINATION, VISUAL |
3 |
0.0001 |
| 593 |
FEAR OF INJECTION |
1 |
0.0001 |
| 594 |
BREAST CANCER |
13 |
0.0001 |
| 595 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 596 |
SWELLING |
13 |
0.0001 |
| 597 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 598 |
PANIC REACTION |
1 |
0.0001 |
| 599 |
DRUG INEFFECTIVE |
178 |
0.0001 |
| 600 |
FEELING DRUNK |
1 |
0.0001 |
| 601 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 602 |
URTICARIA |
22 |
0.0001 |
| 603 |
FEELING HOT |
8 |
0.0001 |
| 604 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 605 |
VOMITING |
61 |
0.0001 |
| 606 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 607 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 608 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 609 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
2 |
0.0001 |
| 610 |
HALLUCINATION, AUDITORY |
2 |
0.0001 |
| 611 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 612 |
BLOOD DISORDER |
1 |
0.0001 |
| 613 |
CONTUSION |
12 |
0.0001 |
| 614 |
NIGHT SWEATS |
4 |
0.0001 |
| 615 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 616 |
FIBROMYALGIA |
3 |
0.0001 |
| 617 |
PRESYNCOPE |
3 |
0.0001 |
| 618 |
FOETAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 619 |
ASPHYXIA |
1 |
0.0001 |
| 620 |
POLYURIA |
1 |
0.0001 |
| 621 |
HICCUPS |
1 |
0.0001 |
| 622 |
PSYCHOMOTOR HYPERACTIVITY |
2 |
0.0001 |
| 623 |
AGEUSIA |
3 |
0.0001 |
| 624 |
HEMIPLEGIA |
1 |
0.0001 |
| 625 |
FUNGAL INFECTION |
4 |
0.0001 |
| 626 |
URINARY RETENTION |
4 |
0.0001 |
| 627 |
HAEMODIALYSIS |
1 |
0.0001 |
| 628 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 629 |
HEMIPARESIS |
2 |
0.0001 |
| 630 |
FLUID RETENTION |
6 |
0.0001 |
| 631 |
INJECTION SITE SWELLING |
9 |
0.0001 |
| 632 |
MUSCULOSKELETAL DISCOMFORT |
2 |
0.0001 |
| 633 |
DEVICE DEFECTIVE |
2 |
0.0001 |
| 634 |
DELIRIUM |
4 |
0.0001 |
| 635 |
NAIL DISORDER |
1 |
0.0001 |
| 636 |
SYRINGE ISSUE |
2 |
0.0001 |
| 637 |
GROIN PAIN |
1 |
0.0001 |
| 638 |
COLD SWEAT |
2 |
0.0001 |
| 639 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 640 |
INJECTION SITE HAEMORRHAGE |
9 |
0.0001 |
| 641 |
BREAST CANCER FEMALE |
3 |
0.0001 |
| 642 |
ISCHAEMIC STROKE |
2 |
0.0001 |
| 643 |
HAEMARTHROSIS |
1 |
0.0001 |
| 644 |
DEVELOPMENTAL DELAY |
1 |
0.0001 |
| 645 |
CRYING |
4 |
0.0001 |
| 646 |
PATHOGEN RESISTANCE |
1 |
0.0001 |
| 647 |
MUSCLE SPASMS |
20 |
0.0001 |
| 648 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 649 |
DYSURIA |
4 |
0.0001 |
| 650 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 651 |
COMA |
5 |
0.0001 |
| 652 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 653 |
RASH ERYTHEMATOUS |
5 |
0.0001 |
| 654 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 655 |
ATELECTASIS |
1 |
0.0001 |
| 656 |
RASH |
45 |
0.0001 |
| 657 |
HEPATIC ENZYME INCREASED |
7 |
0.0001 |
| 658 |
SURGERY |
6 |
0.0001 |
| 659 |
DIZZINESS |
51 |
0.0001 |
| 660 |
MULTIPLE SCLEROSIS RELAPSE |
7 |
0.0001 |
| 661 |
HEPATOMEGALY |
1 |
0.0001 |
| 662 |
LABORATORY TEST ABNORMAL |
3 |
0.0001 |
| 663 |
PSYCHOTIC DISORDER |
3 |
0.0001 |
| 664 |
LOSS OF CONSCIOUSNESS |
13 |
0.0001 |
| 665 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 666 |
DEVICE MALFUNCTION |
7 |
0.0001 |
| 667 |
APHASIA |
3 |
0.0001 |
| 668 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 669 |
PRURITUS |
38 |
0.0001 |
| 670 |
HYPOTHERMIA |
1 |
0.0001 |
| 671 |
EAR DISCOMFORT |
1 |
0.0001 |
| 672 |
EMOTIONAL DISORDER |
3 |
0.0001 |
| 673 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 674 |
ABDOMINAL DISCOMFORT |
16 |
0.0001 |
| 675 |
DERMATITIS ATOPIC |
5 |
0.0001 |
| 676 |
INCONTINENCE |
1 |
0.0001 |
| 677 |
DRUG INTERACTION |
15 |
0.0001 |
| 678 |
MIGRAINE |
9 |
0.0001 |
| 679 |
FATIGUE |
73 |
0.0001 |
| 680 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 681 |
LACTIC ACIDOSIS |
3 |
0.0001 |
| 682 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 683 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 684 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 685 |
NEOPLASM MALIGNANT |
6 |
0.0001 |
| 686 |
PULMONARY OEDEMA |
4 |
0.0001 |
| 687 |
FLATULENCE |
5 |
0.0001 |
| 688 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 689 |
MICTURITION URGENCY |
1 |
0.0001 |
| 690 |
NEOPLASM |
1 |
0.0001 |
| 691 |
ADVERSE EVENT |
8 |
0.0001 |
| 692 |
METASTASES TO LUNG |
1 |
0.0001 |
| 693 |
NEOPLASM PROGRESSION |
3 |
0.0001 |
| 694 |
HYPERSENSITIVITY |
16 |
0.0001 |
| 695 |
MADAROSIS |
1 |
0.0001 |
| 696 |
HAEMORRHAGE |
9 |
0.0001 |
| 697 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 698 |
EYELID OEDEMA |
1 |
0.0001 |
| 699 |
CONDITION AGGRAVATED |
26 |
0.0001 |
| 700 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
3 |
0.0001 |
| 701 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
3 |
0.0001 |
| 702 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 703 |
PANIC ATTACK |
3 |
0.0001 |
| 704 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 705 |
DYSPEPSIA |
8 |
0.0001 |
| 706 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 707 |
EYE SWELLING |
3 |
0.0001 |
| 708 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 709 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 710 |
HYPOPHAGIA |
2 |
0.0001 |
| 711 |
CONSTIPATION |
17 |
0.0001 |
| 712 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 713 |
HIATUS HERNIA |
1 |
0.0001 |
| 714 |
RASH GENERALISED |
2 |
0.0001 |
| 715 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 716 |
ASTHENIA |
29 |
0.0001 |
| 717 |
NODULE |
1 |
0.0001 |
| 718 |
SPEECH DISORDER |
4 |
0.0001 |
| 719 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 720 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 721 |
ADVERSE REACTION |
1 |
0.0001 |
| 722 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 723 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 724 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 725 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 726 |
JAUNDICE |
2 |
0.0001 |
| 727 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 728 |
LIMB INJURY |
2 |
0.0001 |
| 729 |
HYPOAESTHESIA |
11 |
0.0001 |
| 730 |
INFLUENZA LIKE ILLNESS |
6 |
0.0001 |
| 731 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 732 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 733 |
MEDICATION ERROR |
4 |
0.0001 |
| 734 |
HUNGER |
1 |
0.0001 |
| 735 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 736 |
WEIGHT INCREASED |
16 |
0.0001 |
| 737 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 738 |
SLEEP DISORDER |
5 |
0.0001 |
| 739 |
OSTEOARTHRITIS |
3 |
0.0001 |
| 740 |
RENAL FAILURE ACUTE |
3 |
0.0001 |
| 741 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 742 |
MUSCULAR WEAKNESS |
8 |
0.0001 |
| 743 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 744 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 745 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 746 |
FLUID OVERLOAD |
1 |
0.0001 |
| 747 |
RESPIRATORY FAILURE |
5 |
0.0001 |
| 748 |
BONE PAIN |
4 |
0.0001 |
| 749 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 750 |
CHILLS |
8 |
0.0001 |
| 751 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 752 |
JOINT SWELLING |
8 |
0.0001 |
| 753 |
CONTRAINDICATED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 754 |
ILL-DEFINED DISORDER |
4 |
0.0001 |
| 755 |
SKIN IRRITATION |
3 |
0.0001 |
| 756 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 757 |
EPILEPSY |
2 |
0.0001 |
| 758 |
INSURANCE ISSUE |
1 |
0.0001 |
| 759 |
LYMPHOMA |
1 |
0.0001 |
| 760 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 761 |
DELUSION |
1 |
0.0001 |
| 762 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 763 |
PYREXIA |
22 |
0.0001 |
| 764 |
PARAESTHESIA |
10 |
0.0001 |
| 765 |
ARRHYTHMIA |
3 |
0.0001 |
| 766 |
ABDOMINAL PAIN UPPER |
13 |
0.0001 |
| 767 |
PNEUMOTHORAX |
1 |
0.0001 |
| 768 |
MULTIPLE SCLEROSIS |
3 |
0.0001 |
| 769 |
ABSCESS |
1 |
0.0001 |
| 770 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
3 |
0.0001 |
| 771 |
INCORRECT DOSE ADMINISTERED |
14 |
0.0001 |
| 772 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 773 |
DEVICE DIFFICULT TO USE |
4 |
0.0001 |
| 774 |
TREATMENT FAILURE |
5 |
0.0001 |
| 775 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 776 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 777 |
COAGULOPATHY |
1 |
0.0001 |
| 778 |
GAIT INABILITY |
2 |
0.0001 |
| 779 |
ANXIETY |
17 |
0.0001 |
| 780 |
EYE PRURITUS |
2 |
0.0001 |
| 781 |
PERICARDITIS |
1 |
0.0001 |
| 782 |
FACE OEDEMA |
1 |
0.0001 |
| 783 |
METRORRHAGIA |
1 |
0.0001 |
| 784 |
THERAPY CESSATION |
3 |
0.0001 |
| 785 |
FEELING ABNORMAL |
14 |
0.0001 |
| 786 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 787 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 788 |
ECZEMA |
3 |
0.0001 |
| 789 |
LOCAL SWELLING |
1 |
0.0001 |
| 790 |
RASH MACULAR |
2 |
0.0001 |
| 791 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 792 |
PRODUCT STORAGE ERROR |
5 |
0.0001 |
| 793 |
AMENORRHOEA |
1 |
0.0001 |
| 794 |
DEPRESSED MOOD |
3 |
0.0001 |
| 795 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 796 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 797 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 798 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 799 |
UNDERDOSE |
4 |
0.0001 |
| 800 |
SOMNOLENCE |
11 |
0.0001 |
| 801 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 802 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 803 |
NECK PAIN |
3 |
0.0001 |
| 804 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 805 |
ASTHMA |
6 |
0.0001 |
| 806 |
ACNE |
4 |
0.0001 |
| 807 |
FOOT FRACTURE |
1 |
0.0001 |
| 808 |
PULMONARY EMBOLISM |
5 |
0.0001 |
| 809 |
MALAISE |
23 |
0.0001 |
| 810 |
ANAEMIA |
10 |
0.0001 |
| 811 |
PAIN |
32 |
0.0001 |
| 812 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 813 |
HAEMORRHOIDS |
1 |
0.0001 |
| 814 |
CHOKING |
1 |
0.0001 |
| 815 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 816 |
HEART RATE INCREASED |
5 |
0.0001 |
| 817 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 818 |
HYPOTENSION |
10 |
0.0000 |
| 819 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 820 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 821 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 822 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 823 |
INSOMNIA |
13 |
0.0000 |
| 824 |
ERYTHEMA |
10 |
0.0000 |
| 825 |
POLLAKIURIA |
2 |
0.0000 |
| 826 |
DECREASED APPETITE |
11 |
0.0000 |
| 827 |
BACK PAIN |
11 |
0.0000 |
| 828 |
JOINT INJURY |
1 |
0.0000 |
| 829 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 830 |
WEIGHT DECREASED |
13 |
0.0000 |
| 831 |
DIARRHOEA |
30 |
0.0000 |
| 832 |
HYPOACUSIS |
2 |
0.0000 |
| 833 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 834 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 835 |
SWELLING FACE |
3 |
0.0000 |
| 836 |
PRODUCT DOSE OMISSION |
3 |
0.0000 |
| 837 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 838 |
PERIPHERAL SWELLING |
7 |
0.0000 |
| 839 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 840 |
HEPATOTOXICITY |
1 |
0.0000 |
| 841 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 842 |
THROAT IRRITATION |
2 |
0.0000 |
| 843 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 844 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 845 |
CHEST PAIN |
8 |
0.0000 |
| 846 |
RENAL DISORDER |
2 |
0.0000 |
| 847 |
DYSPHAGIA |
4 |
0.0000 |
| 848 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 849 |
SKIN BURNING SENSATION |
3 |
0.0000 |
| 850 |
MOBILITY DECREASED |
3 |
0.0000 |
| 851 |
MYALGIA |
7 |
0.0000 |
| 852 |
BRONCHITIS |
3 |
0.0000 |
| 853 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 854 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
8 |
0.0000 |
| 855 |
GASTRIC CANCER |
1 |
0.0000 |
| 856 |
DRUG RESISTANCE |
1 |
0.0000 |
| 857 |
OFF LABEL USE |
34 |
0.0000 |
| 858 |
INFLAMMATION |
2 |
0.0000 |
| 859 |
NO ADVERSE EVENT |
7 |
0.0000 |
| 860 |
HAEMATOMA |
1 |
0.0000 |
| 861 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 862 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 863 |
ARTHRALGIA |
16 |
0.0000 |
| 864 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 865 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 866 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 867 |
PAIN IN EXTREMITY |
11 |
0.0000 |
| 868 |
THROMBOSIS |
3 |
0.0000 |
| 869 |
FEAR |
1 |
0.0000 |
| 870 |
RASH PRURITIC |
2 |
0.0000 |
| 871 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 872 |
VISION BLURRED |
5 |
0.0000 |
| 873 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 874 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 875 |
HAEMOPTYSIS |
1 |
0.0000 |
| 876 |
ALOPECIA |
7 |
0.0000 |
| 877 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 878 |
CEREBROVASCULAR ACCIDENT |
6 |
0.0000 |
| 879 |
ANGINA PECTORIS |
1 |
0.0000 |
| 880 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 881 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 882 |
WHEEZING |
2 |
0.0000 |
| 883 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 884 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 885 |
VERTIGO |
2 |
0.0000 |
| 886 |
BLOOD PRESSURE INCREASED |
5 |
0.0000 |
| 887 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 888 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 889 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 890 |
HEAD INJURY |
1 |
0.0000 |
| 891 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 892 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 893 |
DEPRESSION |
7 |
0.0000 |
| 894 |
AMNESIA |
2 |
0.0000 |
| 895 |
PSORIASIS |
4 |
0.0000 |
| 896 |
PRODUCT DOSE OMISSION ISSUE |
9 |
0.0000 |
| 897 |
CHOLELITHIASIS |
1 |
0.0000 |
| 898 |
TREMOR |
5 |
0.0000 |
| 899 |
DEHYDRATION |
4 |
0.0000 |
| 900 |
ANGER |
1 |
0.0000 |
| 901 |
SINUSITIS |
3 |
0.0000 |
| 902 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 903 |
HYPERKALAEMIA |
1 |
0.0000 |
| 904 |
INJURY |
2 |
0.0000 |
| 905 |
HYPOXIA |
1 |
0.0000 |
| 906 |
HYPERTENSION |
6 |
0.0000 |
| 907 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 908 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 909 |
OVERDOSE |
6 |
0.0000 |
| 910 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 911 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 912 |
DYSARTHRIA |
1 |
0.0000 |
| 913 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 914 |
HOSPITALISATION |
4 |
0.0000 |
| 915 |
SEIZURE |
3 |
0.0000 |
| 916 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 917 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 918 |
DISORIENTATION |
1 |
0.0000 |
| 919 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 920 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 921 |
BLINDNESS |
1 |
0.0000 |
| 922 |
DRUG DOSE OMISSION |
4 |
0.0000 |
| 923 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 924 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 925 |
HYPERHIDROSIS |
3 |
0.0000 |
| 926 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 927 |
COVID-19 |
4 |
0.0000 |
| 928 |
ANGIOEDEMA |
1 |
0.0000 |
| 929 |
LIVER DISORDER |
1 |
0.0000 |
| 930 |
DRY SKIN |
3 |
0.0000 |
| 931 |
NEUTROPENIA |
3 |
0.0000 |
| 932 |
CARDIAC DISORDER |
2 |
0.0000 |
| 933 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 934 |
FALL |
7 |
0.0000 |
| 935 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 936 |
LUNG DISORDER |
1 |
0.0000 |
| 937 |
DRY EYE |
1 |
0.0000 |
| 938 |
LEUKOPENIA |
1 |
0.0000 |
| 939 |
CELLULITIS |
1 |
0.0000 |
| 940 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 941 |
PANCREATITIS |
1 |
0.0000 |
| 942 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 943 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 944 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 945 |
ARTHROPATHY |
1 |
0.0000 |
| 946 |
INFLUENZA |
2 |
0.0000 |
| 947 |
SEPSIS |
2 |
0.0000 |
| 948 |
BLISTER |
1 |
0.0000 |
| 949 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 950 |
EYE PAIN |
1 |
0.0000 |
| 951 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 952 |
CONVULSION |
1 |
0.0000 |
| 953 |
HERPES ZOSTER |
1 |
0.0000 |
| 954 |
LETHARGY |
1 |
0.0000 |
| 955 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 956 |
NASAL CONGESTION |
1 |
0.0000 |
| 957 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 958 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 959 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 960 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 961 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 962 |
DEVICE EXPULSION |
1 |
0.0000 |
| 963 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 964 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 965 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 966 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 967 |
DYSGEUSIA |
1 |
0.0000 |
| 968 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 969 |
DRY MOUTH |
1 |
0.0000 |
| 970 |
CARDIAC ARREST |
1 |
0.0000 |
| 971 |
DRUG ABUSE |
1 |
0.0000 |
| 972 |
BALANCE DISORDER |
1 |
0.0000 |
| 973 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 974 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 975 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 976 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 977 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 978 |
COUGH |
3 |
0.0000 |
| 979 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 980 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 981 |
FLUSHING |
1 |
0.0000 |
| 982 |
ILLNESS |
1 |
0.0000 |
| 983 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 984 |
PNEUMONIA |
3 |
0.0000 |
| 985 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 986 |
INFECTION |
1 |
0.0000 |
| 987 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 988 |
DEATH |
1 |
0.0000 |